Compare · GKOS vs MMM
GKOS vs MMM
Side-by-side comparison of Glaukos Corporation (GKOS) and 3M Company (MMM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GKOS and MMM operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MMM is the larger of the two at $83.37B, about 9.1x GKOS ($9.21B).
- GKOS has been more active in the news (16 items in the past 4 weeks vs 10 for MMM).
- Both have 25 recent analyst ratings on file.
- Company
- Glaukos Corporation
- 3M Company
- Price
- -
- -
- Market cap
- $9.21B
- $83.37B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NYSE
- IPO
- 2015
- News (4w)
- 16
- 10
- Recent ratings
- 25
- 25
Glaukos Corporation
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite for use as a standalone procedure in patients with refractory glaucoma; iStent SA, a two-stent product that is designed for use as a standalone glaucoma procedure; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.
3M Company
3M Company develops, manufactures, and markets various products worldwide. It operates through four business segments: Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. The Safety and Industrial segment offers personal safety products, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules to industrial, electrical, and safety markets. The Transportation and Electronics provides electronics, such as display materials and systems, electronic materials solutions; automotive and aerospace, and commercial solutions; advanced materials; and transportation safety products to transportation and electronic original equipment manufacturer customers. The Health Care segment offers medical and surgical supplies, skin health and infection prevention products, oral care, separation and purification sciences, health information systems, drug delivery systems, and food safety products to healthcare industry. The Consumer segment provides home improvement, home care, and consumer health care products, as well as stationery and office supplies to various consumers. This segment is also involved in the retail auto care business. It offers its products through various e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers, as well as directly to users. 3M Company has a strategic collaboration with Merry Maids in residential cleaning sector; and collaborations with The Infectious Disease Research Institute and Duke Human Vaccine Institute to create a vaccine candidate with potential to provide protection against multiple variants of SARS-CoV-2. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.
Latest GKOS
- SVP & CHIEF FINANCIAL OFFICER Thurman Alex R. exercised 10,000 shares at a strike of $38.68 and sold $1,550,000 worth of shares (10,000 units at $155.00) as part of a pre-agreed trading plan (SEC Form 4)
- SVP & CHIEF FINANCIAL OFFICER Thurman Alex R. exercised 10,000 shares at a strike of $38.68 and sold $1,500,000 worth of shares (10,000 units at $150.00) as part of a pre-agreed trading plan (SEC Form 4)
- CHIEF DEVELOPMENT OFFICER Navratil Tomas sold $99,567 worth of shares (716 units at $139.06) as part of a pre-agreed trading plan, decreasing direct ownership by 0.81% to 87,634 units (SEC Form 4)
- Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29
- H.C. Wainwright initiated coverage on Glaukos with a new price target
- CHAIRMAN & CEO Burns Thomas William covered exercise/tax liability with 4,059 shares, decreasing direct ownership by 6% to 68,967 units (SEC Form 4) to satisfy withholding obligation
- PRESIDENT & COO Gilliam Joseph E covered exercise/tax liability with 1,056 shares, decreasing direct ownership by 1% to 72,363 units (SEC Form 4) to satisfy withholding tax
- CHIEF DEVELOPMENT OFFICER Navratil Tomas covered exercise/tax liability with 483 shares, decreasing direct ownership by 0.54% to 88,350 units (SEC Form 4) to satisfy withholding tax
- Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis
- Amendment: SEC Form 4 filed by Director Foley Mark J
Latest MMM
- 3M upgraded by Analyst with a new price target
- 3M and Microsoft announce strategic partnership to advance AI data center infrastructure and enterprise transformation
- Scotch™ Brand launches Scotch Kids® Tape for young creators
- 3M Announces Upcoming Investor Event
- 3M Young Scientist Challenge Names 10 Finalists for 2026 National Competition
- Group President Bauer Wendy A exercised 7,952 shares at a strike of $159.96 and covered exercise/tax liability with 3,558 shares, increasing direct ownership by 94% to 9,086 units (SEC Form 4)
- 3M and Discovery Education announce 37 State Merit Winners and four Honorable Mentions in 2026 3M Young Scientist Challenge
- 3M joins Cadillac Formula 1® Team as Official Material Science Partner to accelerate racing performance
- 3M and Airbus announce agreement to advance A220 passenger comfort and aircraft performance through advanced insulation technology
- 3M launches Ask 3M, an AI-powered tool for faster access to technical expertise